Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396:1204–22.
Hough KP, Curtiss ML, Blain TJ, et al. Airway remodeling in asthma. Front Med. 2020;7:191.
Peng S, Gao J, Liu W, et al. Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-κB signaling and NLRP3 inflammasome activation. Oncotarget. 2016;7:80262.
Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci. 2006;103:13180–5.
Chen Q, Yang W, Wang X, et al. TGF-β1 induces EMT in bovine mammary epithelial cells through the TGFβ1/Smad signaling pathway. Cell Physiol Biochem. 2017;43:82–93.
Zhou Y, Lee J-Y, Lee C-M, et al. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis. J Biol Chem. 2012;287:41991–2000.
Stahler A, Stintzing S, Modest DP, et al. Amphiregulin expression is a predictive biomarker for EGFR inhibition in metastatic colorectal cancer: combined analysis of three randomized trials. Clin Cancer Res. 2020;26:6559–67.
Berasain C, Avila MA. Amphiregulin. Elsevier 2014. 31–41.
Effenberger T, von der Heyde J, Bartsch K, et al. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding. FASEB J. 2014;28:4847–56.
Monticelli LA, Osborne LC, Noti M, et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactions. Proc Natl Acad Sci. 2015;112:10762–7.
Perugorria MJ, Latasa MU, Nicou A, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008;48:1251–61.
Du B, Altorki NK, Kopelovich L, et al. Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism. Can Res. 2005;65:5982–8.
Inoue H, Akimoto K, Homma T, et al. Airway epithelial dysfunction in asthma: relevant to epidermal growth factor receptors and airway epithelial cells. J Clin Med. 2020;9:3698.
Enomoto Y, Orihara K, Takamasu T, et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol. 2009;124:913–20.
Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig. 2003;112:1776–84.
Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Investig. 2009;119:1429–37.
Valcourt U, Kowanetz M, Niimi H, et al. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell. 2005;16:1987–2002.
Xu J, Lamouille S, Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156–72.
Lipson KE, Wong C, Teng Y, et al. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. BioMed Central 2012; 1–8.
Wang Y, Chang T, Wu T, et al. Connective tissue growth factor promotes retinal pigment epithelium mesenchymal transition via the PI3K/AKT signaling pathway. Mol Med Rep. 2021;23:1–13.
Lin C-H, Yu M-C, Tung W-H, et al. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Biochimica et Biophysica Acta (BBA) Mol Cell Res. 2013;1833:2823–33.
Sonnylal S, Xu S, Jones H, et al. Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro. J Cell Sci. 2013;126:2164–75.
Cheng Y, Lin C, Chen J-Y, et al. Correction: induction of connective tissue growth factor expression by hypoxia in human lung fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 pathways. PLoS ONE. 2017;12: e0188608.
Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog. 2007;46:591–8.
Yan D, An G, Kuo MT. C-Jun N-terminal kinase signalling pathway in response to cisplatin. J Cell Mol Med. 2016;20:2013–9.
Wu Y, Zhou J, Wang H, et al. The activation of p38 MAPK limits the abnormal proliferation of vascular smooth muscle cells induced by high sodium concentrations. Int J Mol Med. 2016;37:74–82.
Cheng W-H, Chen C-L, Chen J-Y, et al. Hypoxia-induced preadipocyte factor 1 expression in human lung fibroblasts through ERK/PEA3/c-Jun pathway. Mol Med. 2021;27:1–14.
Venter C, Niesler C. Rapid quantification of cellular proliferation and migration using ImageJ. Biotechniques. 2019;66:99–102.
Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochimica et Biophysica Acta (BBA) Mol Cell Res. 2007;1773:1341–8.
Lee M-Y, Shin I-S, Jeon W-Y, et al. Bangpungtongseong-san, a traditional herbal medicine, attenuates chronic asthmatic effects induced by repeated ovalbumin challenge. Int J Mol Med. 2014;33:978–86.
Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation—ECM deposition in airway and possible therapy for remodeling. Allergol Int. 2007;56:321–9.
Bergeron C, Al-Ramli W, Hamid Q. Remodeling in asthma. Proc Am Thorac Soc. 2009;6:301–5.
Zhou X-L, Xu P, Chen H-H, et al. Thalidomide inhibits TGF-β1-induced epithelial to mesenchymal transition in alveolar epithelial cells via Smad-dependent and Smad-independent signaling pathways. Sci Rep. 2017;7:1–10.
Yu L, Hébert MC, Zhang YE. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J. 2002;21:3749–59.
Massagué J, Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 2000;19:1745–54.
Song P, Zheng J, Xu J, et al. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis. Mol Med Rep. 2015;11:2703–10.
Zaiss DM, Gause WC, Osborne LC, et al. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity. 2015;42:216–26.
Stolarczyk M, Amatngalim GD, Yu X, et al. ADAM 17 and EGFR regulate IL-6 receptor and amphiregulin mRNA expression and release in cigarette smoke-exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD). Physiol Rep. 2016;4: e12878.
Kim KW, Jee HM, Park YH, et al. Relationship between amphiregulin and airway inflammation in children with asthma and eosinophilic bronchitis. Chest. 2009;136:805–10.
Adib-Conquy M, Pedron T, Petit-Bertron A-F, et al. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med. 2008;14:36–44.
Chun Y, Do A, Grishina G, et al. Integrative study of the upper and lower airway microbiome and transcriptome in asthma. JCI insight 2020;5.
Hachim MY, Elemam NM, Ramakrishnan RK, et al. Blood and salivary amphiregulin levels as biomarkers for asthma. Front Med. 2020;7:670.
Novali M, Hirota N, Hassan M, et al. Amphiregulin expression correlates with asthma severity in human bronchial epithelial cells and is released by histamine. In: C38. AIRWAY INFLAMMATION: FROM MECHANISMS TO NON-INVASIVE BIOMARKERS. American Thoracic Society 2011. A4449–A4449.
Yasuda Y, Nagano T, Kobayashi K, et al. Group 2 innate lymphoid cells and the house dust mite-induced asthma mouse model. Cells. 2020;9:1178.
Morimoto Y, Hirahara K, Kiuchi M, et al. Amphiregulin-producing pathogenic memory T helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis. Immunity. 2018;49:134–50.
Shafieian M, Chen S, Wu S. Integrin-linked kinase mediates CTGF-induced epithelial to mesenchymal transition in alveolar type II epithelial cells. Pediatr Res. 2015;77:520–7.
Wang X, Wu G, Gou L, et al. A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice. Respirology. 2011;16:500–7.
Xu J, Xu X, Jiang L, et al. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir Res. 2020;21:1–12.
Chen Y, Abraham DJ, Shi-Wen X, et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 2004;15:5635–46. https://doi.org/10.1091/mbc.e04-06-0490.
Ou S-C, Bai K-J, Cheng W-H, et al. TGF-β induced CTGF expression in human lung epithelial cells through ERK, ADAM17, RSK1, and C/EBPβ pathways. Int J Mol Sci. 2020;21:9084.
Chen J-Y, Cheng W-H, Lee K-Y, et al. Abnormal ADAM17 expression causes airway fibrosis in chronic obstructive asthma. Biomed Pharmacother. 2021;140: 111701.
Sisto M, Ribatti D, Lisi S. ADAM 17 and epithelial-to-mesenchymal transition: the evolving story and its link to fibrosis and cancer. J Clin Med. 2021;10:3373.
Lee C-M, Park JW, Cho W-K, et al. Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis. Korean J Intern Med. 2014;29:281.
Puddicombe SM, Polosa R, Richter A, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000;14:1362–74.